Clinical Trials | May 20, 2023
Moderna presents Phase 1/2 of MRNA-3927at 2023 ASGCT Meeting
First clinical trial reporting results of an mRNA therapeutic for intracellular protein replacement
First clinical trial reporting results of an mRNA therapeutic for intracellular protein replacement
The additional $50 million will go towards venture capital firms that specialize in near- and long-term healthcare solutions for patients in low- and middle-income countries
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
Acquisition of XinThera provides Gilead with precision small molecules focused on PARP1 and MK2 Inhibitors
Sunrise is built on four elements i.e., Awareness, Screening & Diagnosis, Treatment, and Maintenance Support
Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease
The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
Pheezee is designed to assess musculoskeletal and neuromuscular health.
PredOmix has developed a novel blood test that can detect about 32 cancers in both men and women with 98 percent accuracy
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
